Table 3.
Se (μg/g) | No. Deaths | Crude HR (95% CI) | (n=254) Multivariate HR (95% CI)* | p-value | (n=210) Multivariate HR (95% CI)** | p-value |
---|---|---|---|---|---|---|
<0.742 | 24 | Ref | Ref | ---- | Ref | ---- |
0.743–0.890 | 70 | 1.22 (0.77, 1.94) | 1.17 (0.73, 1.87) | 0.523 | 0.98 (0.59, 1.62) | 0.92 |
0.891–1.037 | 59 | 1.25 (0.78, 2.01) | 1.38 (0.85, 2.25) | 0.20 | 1.18 (0.69, 2.00) | 0.54 |
>1.037 | 21 | 1.07 (0.59, 1.92) | 1.08 (0.59, 1.98) | 0.81 | 0.99 (0.52, 1.88) | 0.97 |
| ||||||
Trend | 1.06 (0.89, 1.26) | 0.50 | 1.04 (0.86, 1.25) | 0.70 |
Model adjusted for age (5 year groups), gender, and histology (GBM, high grade astrocytoma, high grade pure/mixed oligodendroglioma).
Restricted to cases with KPS data. Model adjusted for age (5 year groups), gender, histology (GBM, high grade astrocytoma, high grade pure/mixed oligodendroglioma), and KPS group